Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
Elli Narvi(University of Turku), Klaus Elenius(University of Turku)
Cited by 11
Related Papers
Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells
|Clinical Cancer Research|2006|265
Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α Signaling
|Journal of Biological Chemistry|2012|44
An unbiased in vitro screen for activating epidermal growth factor receptor mutations
|Journal of Biological Chemistry|2019|28
The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration
|Journal of Biological Chemistry|2020|17
Hypoxia-inducible Factor-1α Induces ErbB4 Signaling in the Differentiating Mammary Gland
|Journal of Biological Chemistry|2014|10